Publication | Closed Access

Co-Delivery of erlotinib and resveratrol via nanostructured lipid Carriers: A synergistically promising approach for cell proliferation prevention and ROS-Mediated apoptosis activation

Cell-based Drug DeliveryNanomedicineEngineeringRos-mediated Apoptosis ActivationMedicineCell DeathNanostructured Lipid CarriersNano-drug DeliveryTumor TargetingPharmacologyCell Proliferation PreventionBiomolecular EngineeringOxidative Stress